4th Consortium Meeting
The 4th Consortium meeting of the TransBioLine Project will take place next April, 11th and 12th, 2022. Even though, the meeting will be virtual, we look forward to improving our network collaboration and sharing of [...]
Four LOIs accepted by the FDA
The FDA has decided to Accept the DILI Work Package into the Biomarker Qualification Program. We are very happy to have DIVI, DINI, DIKI and DILI already accepted by the FDA Biomarker Qualification Program! Take [...]
TransBioLine Newsletter Year 2 is online!
We are delighted to announce that the TransBioLine Newsletter Year 2 is online! This Newsletter summarizes the highlights of the scientific progress and the consortium activities during the second year of the project. Don’t want [...]
3rd Consortium Meeting (Online)
TransBioLine 3rd Consortium Meeting took place in an online format on 8-9th September 2020. Up to 90 people joined the virtual TransBioLine 3rd consortium meeting, having the representation of all consortium partners. Project progress was [...]